Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 700 participants.

Also called NCT02641821

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 700 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02641821
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02641821. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension
Condition
Hypertension
Intervention (Drug)
Nifedipine GITS
Lead sponsor
Peking University First Hospital (class: other)
Collaborator
Bayer (class: industry)

Record details

Record id
cardio:ct-nct02641821
Content hash
19d76cf4fbac45357d03ff1e0784180c6c5d31742b2938b8fe0d9200a0736db2